The ocular system can be affected in systemic lupus erythematosus (SLE) in one third of patients. However, optic nerve involvement is relatively uncommon, but is more so in pediatric SLE patients, where it can occur in 1% of cases. We report three children with SLE who presented with optic nerve involvement. Two children had optic neuritis, with optic neuritis being the first manifestation in one child. The third child had ischaemic optic neuropathy secondary to antiphospholipid syndrome. A careful work up for SLE should be performed in every child with optic nerve disease. Prompt diagnosis and early treatment results in a better prognosis.
BrunnerHIGladmanDDIbañezDUrowitzMDSilvermanED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum2008; 58: 556–562.
JabsDAHannekenAMSchachatAPFineSL. Choroidopathy in systemic lupus erythematosus. Arch Ophthalmol1988; 106: 230–234.
11.
AllenIVMillarJHKirkJShillingtonRK. Systemic lupus erythematosus clinically resembling multiple sclerosis and with unusual pathological and ultrastructural features. J Neurol Neurosurg Psychiatry1979; 42: 392–401.
12.
SiatkowskiRMScottIUVermAM. Optic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosus. J Neuroophthalmol2001; 21: 193–198.
13.
Galindo-RodriguezGAvina-ZubietaJAPizarroS. Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial. Am J Med1999; 106: 65–69.
14.
Barile-FabrisLAriza-AndracaROlguinOrtegaL. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis2005; 64: 620–625.
15.
JónsdóttirT. Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response. Ann Rheum Dis2008; 67: 330–334.
